Product NDC: | 0093-4177 |
Proprietary Name: | Cephalexin |
Non Proprietary Name: | Cephalexin |
Active Ingredient(s): | 250 mg/5mL & nbsp; Cephalexin |
Administration Route(s): | ORAL |
Dosage Form(s): | POWDER, FOR SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0093-4177 |
Labeler Name: | Teva Pharmaceuticals USA Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA062703 |
Marketing Category: | ANDA |
Start Marketing Date: | 19900930 |
Package NDC: | 0093-4177-74 |
Package Description: | 200 mL in 1 BOTTLE (0093-4177-74) |
NDC Code | 0093-4177-74 |
Proprietary Name | Cephalexin |
Package Description | 200 mL in 1 BOTTLE (0093-4177-74) |
Product NDC | 0093-4177 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cephalexin |
Dosage Form Name | POWDER, FOR SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 19900930 |
Marketing Category Name | ANDA |
Labeler Name | Teva Pharmaceuticals USA Inc |
Substance Name | CEPHALEXIN |
Strength Number | 250 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |